Trial Profile
Clinical Trials Insight: 700030197
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2008
Price :
$35
*
At a glance
- Drugs Sobetirome (Primary)
- Indications Lipid metabolism disorders
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 30 Jan 2008 New trial record.